INSIGHTS ON DRUG DEVELOPMENT
-
What Is DMPK, And Why Does It Matter In Drug Development?
By leveraging advanced DMPK software solutions, you can streamline your workflows and make informed decisions with confidence.
-
How A Privately Owned CDMO Is Transforming Client Expectations
Finding a partner with flexible services and a strong emphasis on building long-term client relationships can help ensure success for your pharmaceutical product.
-
Pioneers And Visionaries Of Nucleic Acid And Nanoparticle-Based Therapeutics
Explore the future of nucleic acid and nanoparticle-based therapeutics, including mRNA, CRISPR, and gene editing, as experts discuss innovative solutions for complex health challenges.
-
Validating Antibodies With Knock-Out Technologies
Watch to learn about how one company achieves antibody validation through knock-out (KO) technologies as well as the significance of gene KO technologies in the large-scale screening of antibodies.
-
UPLC-MS/MS Determination Of GLP-1 Analogue7/17/2025
Discover a robust, evaporation-free method for analyzing liraglutide in human plasma using LC-MS/MS to ensure high sensitivity, reproducibility, and improved analyte recovery.
-
Increasing Bioavailability With Amorphous Solid Dosage Formulations11/10/2023
Discover the challenges associated with pH-dependent solubility for oral tyrosine kinase inhibitor drugs and how leveraging ASD formulation can help create more effective, patient-friendly drug products.
-
Assessing Viability And Real-Time Apoptosis/Necrosis3/17/2025
Malignant gliomas are aggressive brain tumors that resist standard treatments. Discover why researchers focus on real-time cell death dynamics to develop targeted therapies and promising strategies.
-
5 Trends Impacting CMOs In 20252/4/2025
In 2025, CMOs will navigate Annex 1 compliance, the BioSecure Act’s uncertainty, AI-driven drug development, supply chain challenges from tariffs, and pandemic preparedness strategies.
-
Tablet Manufacturing Technologies For Solid Drug Formulation4/2/2025
Compressed tablets are common oral solid dosages that contain the API and various excipients. Learn about the critical steps in selecting manufacturing methods and excipients to achieve the desired therapeutic effects and stability.
DRUG DEVELOPMENT SOLUTIONS
-
Applied Biosystems genetic analyzer, model 3500, integrated autosampler, 120 volts, serial# 24158-161.
-
Explore how a validated diet-induced mouse model that replicates key features of human NASH can support your preclinical research and therapeutic development.
-
Learn about a manufacturing site with over 35 years of expertise in bioconjugation, APIs, excipients, and adjuvants manufacturing that helps clients accelerate drug development programs worldwide.
-
Our team of analytical experts provides experience, efficiency, and technical proficiency in the development/validation of analytical methodology and GMP testing support for your project.
-
Discover the nanoparticle engineering, formulation and GMP manufacturing services that can drive forward your market success and unlock the power of “small."